NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | 93,000 | $138,896 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BARCLAYS PLC | 475,000 | $705 | 0.00% |
| CITIGROUP INC | 92,000 | $136,482 | 0.00% |
| MORGAN STANLEY | 1,000 | $1,484 | 0.00% |
| COMERICA BANK | 5,000 | $7,418 | 0.00% |
| Leucadia National | 27,000 | $39,872 | 0.00% |
| UBS Group AG | 1,000 | $1,484 | 0.00% |
| JPMORGAN CHASE & CO | 59,000 | $88,500 | 0.00% |
| JANE STREET GROUP, LLC | 259,000 | $393,032 | 0.00% |
| Capital Analysts, LLC | 2,000 | $3 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 10,000 | $14,930 | 0.00% |
This page lists NEUROCRINE BIOSCIENCES INC's shareholders in Q3 2023. To view NEUROCRINE BIOSCIENCES INC's shareholder history, click here.